neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Patient Councelling 2nd year D pharmacy study Notes
1. • Swami Vivekanand Santha’s
Institute of Pharmacy
• Prepared By : Mr.Tanuj Nagmoti
Miss Pooja Pawar
• Guidence By :Miss Disha Khare
. Lecturer (M.Pharm)
Community Pharmacy & Management
3. DEFINATION
• Patient counselling is defined
as providing mediction
information orally or in
written form to the patient or
their representitives on
direction of use, advice on
side effects precaution,
storage, diet and life style
modification.
4. OBJECTIVES:
• Patient should recognise the importance of
medication for his well being.▸ A working
relationship and a foundation for
continuous interaction and consultation
should be established.► Patient
understanding of stratagies to deal with
medication side effect and drug interaction
should be improved.▸ Should ensure
better patient compliance.▸ Patient
becomes an informed, efficient And
activeparticipant in disease treatment and
self care management
6. STEP DURING
PATIENT
COUNSELLING:
• Following are the step to
be followed during patient
counselling:▸ 1) preparing
for the session.▸
2)opening of the session.▸
3)counselling content.▸
4)closing the session.
7. COUNSELLING
CONTENT:
• Name and strength of medication.►
The reason why it has been
prescribed, or how it work.► How to
take the medication.▸ Expected
duration of treatment.▸ Expected
benefit of treatment.► Possible
adverse effect.▸ Possible medication
or dietary interaction.▸ Storage
recommendation.► Minimum
duration required to show therapeutic
bennifit.
9. HYPERTENSION
• . Counselling regarding
diseasePatients with primary
hypertension should be educated
about the disease. With suitable
examples, patients should be given an
idea about the systole, diastole and
pressure created in the blood vessels.
Also, the patients should be explained
about the blood pressure readings
under normal condition and in
hypertension,
12. Diabetes
• Counselling regarding disease
• Patients with diabetes should be
informed that the disease will
remain lifelong and they should
modify their lifestyle.
Pharmacist should also explain
the value of pharmacotherapy,
particularly the necessity of
careful adherence to the
recommended course of
treatment.
15. Asthma
I. Counselling regarding diseaseThe patients
should be informed that the disease will not
affect their children or their neighbors
Additionally, it will not spread by eating
together in the same plates or using each
other’s belongings. If medications are used as
prescribed, the disease’s progression can be
controlled,
18. HIV AIDS
• Develop teaching, educational aids
• In addition to live counselling
• Good for follow up reading by patients
• Medication card: useful aid, has summary of drugs
• Easy format, patient can understand
• Pharma companies draft “Consumer Product Info”
• Pharmacist can also draft simple product info
Counseling
19. Tuberculosis (information about disease)
• Tuberculosis as a disease
which demands long-term
multidrug treatment, whi can
cause serious adverse drug
reactions that can affect the
course of therapy Moreover,
antituberculotic drugs interact
with a variety of drugs, Ot
preparations and food, all of
which can significantly alter
the effectiveness
20. CHRONIC OBSTRUCTIVE
PULMONARY DISEASE
• The role of pharmacists has been recognized in the treatment of
COPD patients, including actions from primary prevention (eg,
educational campaigns), through preliminary diagnostics (eg,
microspirometry testing), to ongoing support and follow-up of
patients and their medications. Special medication counselling
interventions by community pharmacists are found to have a
positive impact on patient and treatment outcomes among
COPD patients.
21. PATIENT PACKAGE INSERT
• “A Patient Package Insert (PPI) or medication guide is a document provide
along with a prescription medication to provide additional information about
that drug.”
• The primary source of drug information is a package insert (PI).
• “Package insert is a document, approved by the administrative licensing
authority, which is provided with the package of a drug.”
• “A package insert, primarily directed at the prescribers, is intended to
provide information for the safe and effective use of the respective drug. It is
also known as Prescription dreg label, Prescribing information.”
22. PATIENT INFORMATION
LEAFLET
• “Patient information leaflets (PILS) are leaflets containing specific
information about medical conditions, doses, side effects that packed with
medicines to give the user information about the product.”
• PIL is the European version of the Package insert.
• The PIL is written by the manufacturing pharmaceutical company
• All licensed medicines need to carry such a leaflet. But to minimize the cost,
manufacturers avoid inserting a PIL.